NXTC
NXTC
NASDAQ · Biotechnology

Nextcure Inc

$8.21
-0.07 (-0.85%)
As of Aug 15, 2:26 AM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +329.4% upside
Low Target $27.20
Average Target $35.25
High Target $53.45
Current Price $8.21
Current
$8.21
Target
$35.25
$27.20 $35.25 avg $53.45
Scenario Analysis
Bear Case
$27.20
231.3%
Low target
Base Case
$35.25
+329.4%
Avg target
Bull Case
$53.45
+551.0%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$15.74
-47.8% from high
52-Week Low
$1.55
+429.7% from low
Target vs 52W High
$35.25
+124.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%